Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2020

01-04-2020 | Original Article

Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis

Authors: Jejo D. Koola, Sam B. Ho, Aize Cao, Guanhua Chen, Amy M. Perkins, Sharon E. Davis, Michael E. Matheny

Published in: Digestive Diseases and Sciences | Issue 4/2020

Login to get access

Abstract

Background

Early hospital readmission for patients with cirrhosis continues to challenge the healthcare system. Risk stratification may help tailor resources, but existing models were designed using small, single-institution cohorts or had modest performance.

Aims

We leveraged a large clinical database from the Department of Veterans Affairs (VA) to design a readmission risk model for patients hospitalized with cirrhosis. Additionally, we analyzed potentially modifiable or unexplored readmission risk factors.

Methods

A national VA retrospective cohort of patients with a history of cirrhosis hospitalized for any reason from January 1, 2006, to November 30, 2013, was developed from 123 centers. Using 174 candidate variables within demographics, laboratory results, vital signs, medications, diagnoses and procedures, and healthcare utilization, we built a 47-variable penalized logistic regression model with the outcome of all-cause 30-day readmission. We excluded patients who left against medical advice, transferred to a non-VA facility, or if the hospital length of stay was greater than 30 days. We evaluated calibration and discrimination across variable volume and compared the performance to recalibrated preexisting risk models for readmission.

Results

We analyzed 67,749 patients and 179,298 index hospitalizations. The 30-day readmission rate was 23%. Ascites was the most common cirrhosis-related cause of index hospitalization and readmission. The AUC of the model was 0.670 compared to existing models (0.649, 0.566, 0.577). The Brier score of 0.165 showed good calibration.

Conclusion

Our model achieved better discrimination and calibration compared to existing models, even after local recalibration. Assessment of calibration by variable parsimony revealed performance improvements for increasing variable inclusion well beyond those detectable for discrimination.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kim WR, Brown RS, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242.CrossRefPubMed Kim WR, Brown RS, Terrault NA, et al. Burden of liver disease in the United States: summary of a workshop. Hepatology. 2002;36:227–242.CrossRefPubMed
2.
go back to reference Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2011;9:524–530.e1. quiz e60. Younossi ZM, Stepanova M, Afendy M, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2011;9:524–530.e1. quiz e60.
3.
go back to reference Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375–382.e1-2.CrossRefPubMed Asrani SK, Larson JJ, Yawn B, et al. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375–382.e1-2.CrossRefPubMed
5.
go back to reference Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.CrossRefPubMed Everhart JE, Ruhl CE. Burden of digestive diseases in the United States Part III: liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–1144.CrossRefPubMed
6.
7.
go back to reference Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(1179–1187):e3. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012;143(1179–1187):e3.
8.
go back to reference Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(1731–1741):e3. Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology. 2015;149(1731–1741):e3.
9.
go back to reference Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(254–272):e11. Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: update 2018. Gastroenterology. 2019;156(254–272):e11.
10.
go back to reference Volk ML. Hospital readmissions for decompensated cirrhosis. Clin Liver Dis. 2014;4:138–140.CrossRef Volk ML. Hospital readmissions for decompensated cirrhosis. Clin Liver Dis. 2014;4:138–140.CrossRef
11.
go back to reference Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.CrossRefPubMed Benbassat J, Taragin M. Hospital readmissions as a measure of quality of health care: advantages and limitations. Arch Intern Med. 2000;160:1074–1081.CrossRefPubMed
12.
go back to reference Halfon P, Eggli Y, Pêtre-Rohrbach I, et al. Validation of the potentially avoidable hospital readmission rate as a routine indicator of the quality of hospital care. Med Care. 2006;44:972–981.CrossRefPubMed Halfon P, Eggli Y, Pêtre-Rohrbach I, et al. Validation of the potentially avoidable hospital readmission rate as a routine indicator of the quality of hospital care. Med Care. 2006;44:972–981.CrossRefPubMed
13.
go back to reference Morales BPP. Early hospital readmission in decompensated cirrhosis: incidence, impact on mortality, and predictive factors. Dig Liver Dis. 2017;49:903–909.CrossRefPubMed Morales BPP. Early hospital readmission in decompensated cirrhosis: incidence, impact on mortality, and predictive factors. Dig Liver Dis. 2017;49:903–909.CrossRefPubMed
14.
go back to reference Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–178.CrossRefPubMed Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–178.CrossRefPubMed
15.
go back to reference Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–1626.CrossRefPubMed Arguedas MR, DeLawrence TG, McGuire BM. Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci. 2003;48:1622–1626.CrossRefPubMed
16.
go back to reference Rakoski MO, McCammon RJ, Piette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012;55:184–191.CrossRefPubMed Rakoski MO, McCammon RJ, Piette JD, et al. Burden of cirrhosis on older Americans and their families: analysis of the health and retirement study. Hepatology. 2012;55:184–191.CrossRefPubMed
17.
go back to reference Bourne RB, Chesworth BM, Davis AM, et al. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468:57–63.CrossRefPubMed Bourne RB, Chesworth BM, Davis AM, et al. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468:57–63.CrossRefPubMed
18.
19.
go back to reference Hansen LO, Young RS, Hinami K, et al. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155:520.CrossRefPubMed Hansen LO, Young RS, Hinami K, et al. Interventions to reduce 30-day rehospitalization: a systematic review. Ann Intern Med. 2011;155:520.CrossRefPubMed
20.
go back to reference Ghaoui RF. Outcomes associated with a mandatory gastroenterology consultation to improve the quality of care of patients hospitalized with decompensated cirrhosis. J Hosp Med Online. 2015;10:236–241.CrossRef Ghaoui RF. Outcomes associated with a mandatory gastroenterology consultation to improve the quality of care of patients hospitalized with decompensated cirrhosis. J Hosp Med Online. 2015;10:236–241.CrossRef
21.
go back to reference Kanwal FA. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016;64:569–581.CrossRefPubMed Kanwal FA. Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis. Hepatology. 2016;64:569–581.CrossRefPubMed
22.
go back to reference Morando FM. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257–264.CrossRefPubMed Morando FM. How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists. J Hepatol. 2013;59:257–264.CrossRefPubMed
23.
go back to reference Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471–480.CrossRefPubMed Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471–480.CrossRefPubMed
24.
go back to reference Koehler BE, Richter KM, Youngblood L, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4:211–218.CrossRefPubMed Koehler BE, Richter KM, Youngblood L, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4:211–218.CrossRefPubMed
25.
go back to reference Amarasingham R, Patzer RE, Huesch M, et al. Implementing electronic health care predictive analytics: considerations and challenges. Health Aff (Millwood). 2014;33:1148–1154.CrossRef Amarasingham R, Patzer RE, Huesch M, et al. Implementing electronic health care predictive analytics: considerations and challenges. Health Aff (Millwood). 2014;33:1148–1154.CrossRef
26.
go back to reference Ohno-Machado L, Resnic FS, Matheny ME. Prognosis in critical care. Annu Rev Biomed Eng. 2006;8:567–599.CrossRefPubMed Ohno-Machado L, Resnic FS, Matheny ME. Prognosis in critical care. Annu Rev Biomed Eng. 2006;8:567–599.CrossRefPubMed
27.
go back to reference Moons KGM, Altman DG, Vergouwe Y, et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009;338:b606.CrossRefPubMed Moons KGM, Altman DG, Vergouwe Y, et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009;338:b606.CrossRefPubMed
28.
go back to reference Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making. 2015;35:162–169.CrossRefPubMed Van Calster B, Vickers AJ. Calibration of risk prediction models: impact on decision-analytic performance. Med Decis Making. 2015;35:162–169.CrossRefPubMed
29.
go back to reference Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–1379.CrossRefPubMed Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol. 1996;49:1373–1379.CrossRefPubMed
30.
go back to reference van der Ploeg T, Austin PC, Steyerberg EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol. 2014;14:137.CrossRefPubMedPubMedCentral van der Ploeg T, Austin PC, Steyerberg EW. Modern modelling techniques are data hungry: a simulation study for predicting dichotomous endpoints. BMC Med Res Methodol. 2014;14:137.CrossRefPubMedPubMedCentral
31.
go back to reference Steyerberg EW, Borsboom GJJM, van Houwelingen HC, et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med. 2004;23:2567–2586.CrossRefPubMed Steyerberg EW, Borsboom GJJM, van Houwelingen HC, et al. Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med. 2004;23:2567–2586.CrossRefPubMed
32.
go back to reference Orman ES, Ghabril M, Emmett TW, et al. Hospital readmissions in patients with cirrhosis: a systematic review. J Hosp Med. 2018;13(7):490–495. Orman ES, Ghabril M, Emmett TW, et al. Hospital readmissions in patients with cirrhosis: a systematic review. J Hosp Med. 2018;13(7):490–495.
33.
go back to reference Berman KT. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.[Erratum appears in Clin Gastroenterol Hepatol. 2011 Jul; 9(7):625 Note: vuppalanch, Raj [corrected to Vuppalanchi, Raj]. Clin Gastroenterol Hepatol. 2011;9:254–259.CrossRefPubMed Berman KT. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.[Erratum appears in Clin Gastroenterol Hepatol. 2011 Jul; 9(7):625 Note: vuppalanch, Raj [corrected to Vuppalanchi, Raj]. Clin Gastroenterol Hepatol. 2011;9:254–259.CrossRefPubMed
34.
go back to reference Singal AGR. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11(1335–1341):e1. Singal AGR. An automated model using electronic medical record data identifies patients with cirrhosis at high risk for readmission. Clin Gastroenterol Hepatol. 2013;11(1335–1341):e1.
35.
go back to reference Bajaj JSR. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200–208.CrossRefPubMed Bajaj JSR. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200–208.CrossRefPubMed
36.
go back to reference Volk ML, Tocco RS, Bazick J, et al. Hospital re-admissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–252.CrossRefPubMed Volk ML, Tocco RS, Bazick J, et al. Hospital re-admissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107:247–252.CrossRefPubMed
37.
go back to reference Tapper EBF. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.CrossRefPubMed Tapper EBF. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–590.CrossRefPubMed
38.
go back to reference Hickey GL, Grant SW, Murphy GJ, et al. Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg. 2013;43:1146–1152.CrossRefPubMed Hickey GL, Grant SW, Murphy GJ, et al. Dynamic trends in cardiac surgery: why the logistic EuroSCORE is no longer suitable for contemporary cardiac surgery and implications for future risk models. Eur J Cardiothorac Surg. 2013;43:1146–1152.CrossRefPubMed
39.
go back to reference Minne L, Eslami S, de Keizer N, et al. Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment. Intensive Care Med. 2012;38:40–46.CrossRefPubMed Minne L, Eslami S, de Keizer N, et al. Effect of changes over time in the performance of a customized SAPS-II model on the quality of care assessment. Intensive Care Med. 2012;38:40–46.CrossRefPubMed
40.
go back to reference Davis SE, Lasko TA, Chen G, et al. Calibration drift in regression and machine learning models for acute kidney injury. J Am Med Inform Assoc. 2017;24:1052–1061.CrossRefPubMedPubMedCentral Davis SE, Lasko TA, Chen G, et al. Calibration drift in regression and machine learning models for acute kidney injury. J Am Med Inform Assoc. 2017;24:1052–1061.CrossRefPubMedPubMedCentral
41.
go back to reference Toll DB, Janssen KJM, Vergouwe Y, et al. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61:1085–1094.CrossRefPubMed Toll DB, Janssen KJM, Vergouwe Y, et al. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61:1085–1094.CrossRefPubMed
42.
go back to reference Moons KGM, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–698.CrossRefPubMed Moons KGM, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98:691–698.CrossRefPubMed
43.
go back to reference Van Calster B, Nieboer D, Vergouwe Y, et al. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167–176.CrossRefPubMed Van Calster B, Nieboer D, Vergouwe Y, et al. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167–176.CrossRefPubMed
44.
go back to reference Van Hoorde K, Van Huffel S, Timmerman D, et al. A spline-based tool to assess and visualize the calibration of multiclass risk predictions. J Biomed Inform. 2015;54:283–293.CrossRefPubMed Van Hoorde K, Van Huffel S, Timmerman D, et al. A spline-based tool to assess and visualize the calibration of multiclass risk predictions. J Biomed Inform. 2015;54:283–293.CrossRefPubMed
45.
go back to reference Nezic D, Borzanovic M, Spasic T, et al. Calibration of the EuroSCORE II risk stratification model: is the Hosmer–Lemeshow test acceptable any more? Eur J Cardiothorac Surg. 2013;43:206.CrossRefPubMed Nezic D, Borzanovic M, Spasic T, et al. Calibration of the EuroSCORE II risk stratification model: is the Hosmer–Lemeshow test acceptable any more? Eur J Cardiothorac Surg. 2013;43:206.CrossRefPubMed
46.
go back to reference Pencina MJ, Peterson ED. Moving from clinical trials to precision medicine: the role for predictive modeling. JAMA. 2016;315:1713–1714.CrossRefPubMed Pencina MJ, Peterson ED. Moving from clinical trials to precision medicine: the role for predictive modeling. JAMA. 2016;315:1713–1714.CrossRefPubMed
47.
go back to reference Parikh RB, Kakad M, Bates DW. Integrating predictive analytics into high-value care: the dawn of precision delivery. JAMA. 2016;315:651.CrossRefPubMed Parikh RB, Kakad M, Bates DW. Integrating predictive analytics into high-value care: the dawn of precision delivery. JAMA. 2016;315:651.CrossRefPubMed
48.
go back to reference Fihn SD, Francis J, Clancy C, et al. Insights from advanced analytics at the Veterans Health Administration. Health Aff Proj Hope. 2014;33:1203–1211.CrossRef Fihn SD, Francis J, Clancy C, et al. Insights from advanced analytics at the Veterans Health Administration. Health Aff Proj Hope. 2014;33:1203–1211.CrossRef
49.
go back to reference Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans, 2001–2013. Gastroenterology. 2015;149(1471–1482):e5. Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US Veterans, 2001–2013. Gastroenterology. 2015;149(1471–1482):e5.
50.
51.
go back to reference Re VL, Lim JK, Goetz MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20:689–699.CrossRefPubMedPubMedCentral Re VL, Lim JK, Goetz MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf. 2011;20:689–699.CrossRefPubMedPubMedCentral
52.
go back to reference Kanwal F, Kramer JR, Buchanan P, et al. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012;143:70–77.CrossRefPubMed Kanwal F, Kramer JR, Buchanan P, et al. The quality of care provided to patients with cirrhosis and ascites in the Department of Veterans Affairs. Gastroenterology. 2012;143:70–77.CrossRefPubMed
53.
go back to reference Vincent P, Larochelle H, Lajoie I, et al. Stacked denoising autoencoders: learning useful representations in a deep network with a local denoising criterion. J Mach Learn Res. 2010;11:3371–3408. Vincent P, Larochelle H, Lajoie I, et al. Stacked denoising autoencoders: learning useful representations in a deep network with a local denoising criterion. J Mach Learn Res. 2010;11:3371–3408.
55.
go back to reference Brown SH, Lincoln MJ, Groen PJ, et al. VistA—U.S. Department of Veterans Affairs national-scale HIS. Int J Med Inf. 2003;69:135–156.CrossRef Brown SH, Lincoln MJ, Groen PJ, et al. VistA—U.S. Department of Veterans Affairs national-scale HIS. Int J Med Inf. 2003;69:135–156.CrossRef
57.
go back to reference Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature. 1999;401:788–791.CrossRefPubMed Lee DD, Seung HS. Learning the parts of objects by non-negative matrix factorization. Nature. 1999;401:788–791.CrossRefPubMed
59.
go back to reference Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B. 1994;58:267–288. Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B. 1994;58:267–288.
60.
go back to reference Steyerberg EW, Eijkemans MJC, Harrell FE, et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059–1079.CrossRefPubMed Steyerberg EW, Eijkemans MJC, Harrell FE, et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Stat Med. 2000;19:1059–1079.CrossRefPubMed
61.
go back to reference Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Berlin: Springer; 2008. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. Berlin: Springer; 2008.
62.
go back to reference Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387.CrossRefPubMed Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361–387.CrossRefPubMed
63.
64.
go back to reference Nattino G, Finazzi S, Bertolini G. A new calibration test and a reappraisal of the calibration belt for the assessment of prediction models based on dichotomous outcomes. Stat Med. 2014;33:2390–2407.CrossRefPubMed Nattino G, Finazzi S, Bertolini G. A new calibration test and a reappraisal of the calibration belt for the assessment of prediction models based on dichotomous outcomes. Stat Med. 2014;33:2390–2407.CrossRefPubMed
65.
go back to reference Pencina MJ, D’Agostino RB, D’Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed Pencina MJ, D’Agostino RB, D’Agostino RB, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–172.CrossRefPubMed
66.
go back to reference Kerr KF, Wang Z, Janes H, et al. Net reclassification indices for evaluating risk-prediction instruments: a critical review. Epidemiol Camb Mass. 2014;25:114–121.CrossRef Kerr KF, Wang Z, Janes H, et al. Net reclassification indices for evaluating risk-prediction instruments: a critical review. Epidemiol Camb Mass. 2014;25:114–121.CrossRef
67.
go back to reference Jiang X, Osl M, Kim J, et al. Calibrating predictive model estimates to support personalized medicine. J Am Med Inform Assoc. 2012;19:263–274.CrossRefPubMed Jiang X, Osl M, Kim J, et al. Calibrating predictive model estimates to support personalized medicine. J Am Med Inform Assoc. 2012;19:263–274.CrossRefPubMed
68.
go back to reference Le SS. Could adherence to quality of care indicators for hospitalized patients with cirrhosis-related ascites improve clinical outcomes? Am J Gastroenterol. 2016;111:87–92.CrossRefPubMed Le SS. Could adherence to quality of care indicators for hospitalized patients with cirrhosis-related ascites improve clinical outcomes? Am J Gastroenterol. 2016;111:87–92.CrossRefPubMed
69.
go back to reference Yang Y-YL. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites. Clin Sci. 2011;121:509–521.CrossRef Yang Y-YL. Identification of diuretic non-responders with poor long-term clinical outcomes: a 1-year follow-up of 176 non-azotaemic cirrhotic patients with moderate ascites. Clin Sci. 2011;121:509–521.CrossRef
70.
go back to reference Gaduputi VC. Prognostic significance of hypokalemia in hepatic encephalopathy. Hepatogastroenterology. 2014;61:1170–1174.PubMed Gaduputi VC. Prognostic significance of hypokalemia in hepatic encephalopathy. Hepatogastroenterology. 2014;61:1170–1174.PubMed
71.
go back to reference Rassameehiran SM. Predictor of 90-day readmission rate for hepatic encephalopathy. South Med J. 2016;109:365–369.CrossRefPubMed Rassameehiran SM. Predictor of 90-day readmission rate for hepatic encephalopathy. South Med J. 2016;109:365–369.CrossRefPubMed
72.
go back to reference Brown CL, Hammill BG, Qualls LG, et al. Significant morbidity and mortality among hospitalized end-stage liver disease patients in medicare. J Pain Symptom Manag. 2016;52(412–419):e1. Brown CL, Hammill BG, Qualls LG, et al. Significant morbidity and mortality among hospitalized end-stage liver disease patients in medicare. J Pain Symptom Manag. 2016;52(412–419):e1.
73.
go back to reference Deitelzweig SA. Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis. Adv Ther. 2013;30:71–80.CrossRefPubMed Deitelzweig SA. Hyponatremia-associated healthcare burden among US patients hospitalized for cirrhosis. Adv Ther. 2013;30:71–80.CrossRefPubMed
74.
go back to reference Bariya M, Nyein HYY, Javey A. Wearable sweat sensors. Nat Electron. 2018;1:160.CrossRef Bariya M, Nyein HYY, Javey A. Wearable sweat sensors. Nat Electron. 2018;1:160.CrossRef
75.
go back to reference Seal KH, Cohen G, Waldrop A, et al. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: implications for screening, diagnosis and treatment. Drug Alcohol Depend. 2011;116:93–101.CrossRefPubMed Seal KH, Cohen G, Waldrop A, et al. Substance use disorders in Iraq and Afghanistan veterans in VA healthcare, 2001–2010: implications for screening, diagnosis and treatment. Drug Alcohol Depend. 2011;116:93–101.CrossRefPubMed
76.
go back to reference Bajaj JS, Wade JB, Gibson DP, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–1653.CrossRefPubMedPubMedCentral Bajaj JS, Wade JB, Gibson DP, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–1653.CrossRefPubMedPubMedCentral
77.
78.
go back to reference Janssen KJM, Moons KGM, Kalkman CJ, et al. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol. 2008;61:76–86.CrossRefPubMed Janssen KJM, Moons KGM, Kalkman CJ, et al. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol. 2008;61:76–86.CrossRefPubMed
79.
go back to reference Kappen TH, Vergouwe Y, van Klei WA, et al. Adaptation of clinical prediction models for application in local settings. Med Decis Making. 2012;32:E1–E10.CrossRefPubMedPubMedCentral Kappen TH, Vergouwe Y, van Klei WA, et al. Adaptation of clinical prediction models for application in local settings. Med Decis Making. 2012;32:E1–E10.CrossRefPubMedPubMedCentral
80.
go back to reference Vergouwe Y, Nieboer D, Oostenbrink R, et al. A closed testing procedure to select an appropriate method for updating prediction models. Stat Med. 2017;36:4529–4539.CrossRefPubMed Vergouwe Y, Nieboer D, Oostenbrink R, et al. A closed testing procedure to select an appropriate method for updating prediction models. Stat Med. 2017;36:4529–4539.CrossRefPubMed
81.
go back to reference Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–371.CrossRefPubMed Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–371.CrossRefPubMed
82.
go back to reference Amarasingham R, Patel PC, Toto K, et al. Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf. 2013;22:998–1005.CrossRefPubMedPubMedCentral Amarasingham R, Patel PC, Toto K, et al. Allocating scarce resources in real-time to reduce heart failure readmissions: a prospective, controlled study. BMJ Qual Saf. 2013;22:998–1005.CrossRefPubMedPubMedCentral
83.
go back to reference Cronin PR, Greenwald JL, Crevensten GC, et al. Development and implementation of a real-time 30-day readmission predictive model. AMIA Annu Symp Proc. 2014;2014:424–431.PubMedPubMedCentral Cronin PR, Greenwald JL, Crevensten GC, et al. Development and implementation of a real-time 30-day readmission predictive model. AMIA Annu Symp Proc. 2014;2014:424–431.PubMedPubMedCentral
84.
go back to reference Leppin AL, Gionfriddo MR, Kessler M, et al. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014;174:1095–1107.CrossRefPubMedPubMedCentral Leppin AL, Gionfriddo MR, Kessler M, et al. Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trials. JAMA Intern Med. 2014;174:1095–1107.CrossRefPubMedPubMedCentral
85.
go back to reference Brock J, Mitchell J, Irby K, et al. Association between quality improvement for care transitions in communities and rehospitalizations among medicare beneficiaries. JAMA. 2013;309:381–391.CrossRefPubMed Brock J, Mitchell J, Irby K, et al. Association between quality improvement for care transitions in communities and rehospitalizations among medicare beneficiaries. JAMA. 2013;309:381–391.CrossRefPubMed
86.
go back to reference Gheorghiade M, Vaduganathan M, Fonarow GC, et al. rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61:391–403.CrossRefPubMed Gheorghiade M, Vaduganathan M, Fonarow GC, et al. rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol. 2013;61:391–403.CrossRefPubMed
87.
go back to reference Tapper EBF. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753–759.CrossRefPubMed Tapper EBF. A quality improvement initiative reduces 30-day rate of readmission for patients with cirrhosis. Clin Gastroenterol Hepatol. 2016;14:753–759.CrossRefPubMed
88.
go back to reference Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.CrossRefPubMed Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.CrossRefPubMed
Metadata
Title
Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis
Authors
Jejo D. Koola
Sam B. Ho
Aize Cao
Guanhua Chen
Amy M. Perkins
Sharon E. Davis
Michael E. Matheny
Publication date
01-04-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05826-w

Other articles of this Issue 4/2020

Digestive Diseases and Sciences 4/2020 Go to the issue

REVIEWER ACKNOWLEDGMENT

Acknowledgment of 2019 Reviewers